wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37724605-9CD78105-B20D-4A75-8933-86DE539E03EE
Q37724605-9CD78105-B20D-4A75-8933-86DE539E03EE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37724605-9CD78105-B20D-4A75-8933-86DE539E03EE
Immunological derangement in hypocellular myelodysplastic syndromes.
P2860
Q37724605-9CD78105-B20D-4A75-8933-86DE539E03EE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37724605-9CD78105-B20D-4A75-8933-86DE539E03EE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
bf9d2fb4779e8d4d555003631acdabcec025779c
P2860
Alemtuzumab treatment of intermediate-1 myelodysplasia patients is associated with sustained improvement in blood counts and cytogenetic remissions.